AMGN's Q4 Earnings Beat, Obesity Candidate Under FDA Clinical Hold

Amgen (AMGN) reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of$5.03 per share. Earnings rose 13% year over year as higher revenues were partially offset by higher operating costs.Total revenues of $9.1 billion also beat the Zacks Consensus Estimate of$8.9 billion. Total revenues rose 11% year over year.Total product revenues increased 11% from the year-ago quarter to $8.72 billion as volume growth was partially offset by continued price declines. ...